Cargando…
The Preclinical Evaluation of a Second-Generation Antivenom for Treating Snake Envenoming in India
Snake envenoming afflicts the Indian subcontinent with the highest rates of mortality (47,000) and morbidity globally. The only effective treatment for snakebites is the administration of antivenom, which is produced by the hyperimmunisation of equines. Commercial Indian antivenoms, however, have be...
Autores principales: | Attarde, Saurabh, Iyer, Ashwin, Khochare, Suyog, Shaligram, Umesh, Vikharankar, Mayur, Sunagar, Kartik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950585/ https://www.ncbi.nlm.nih.gov/pubmed/35324665 http://dx.doi.org/10.3390/toxins14030168 |
Ejemplares similares
-
Venomics of the Enigmatic Andaman Cobra (Naja sagittifera) and the Preclinical Failure of Indian Antivenoms in Andaman and Nicobar Islands
por: Attarde, Saurabh, et al.
Publicado: (2021) -
Biogeographic venom variation in Russell’s viper (Daboia russelii) and the preclinical inefficacy of antivenom therapy in snakebite hotspots
por: Senji Laxme, R. R., et al.
Publicado: (2021) -
Fangs in the Ghats: Preclinical Insights into the Medical Importance of Pit Vipers from the Western Ghats
por: Khochare, Suyog, et al.
Publicado: (2023) -
Beyond the ‘big four’: Venom profiling of the medically important yet neglected Indian snakes reveals disturbing antivenom deficiencies
por: Senji Laxme, R. R., et al.
Publicado: (2019) -
Antivenom for Neuromuscular Paralysis Resulting From Snake Envenoming
por: Silva, Anjana, et al.
Publicado: (2017)